Health Technology Assessment on the use of the Wearable Cardioverter Defibrillator in Patients with Myocardial Infarction and with ICD Explant

Health Technology Assessment on the use of the Wearable Cardioverter Defibrillator in Patients with Myocardial Infarction and with ICD Explant

Authors

  • Paolo Angelo Cortesi Research Centre on Public Health (CESP), University of Milano-Bicocca, Monza, Italy https://orcid.org/0000-0001-5241-4473
  • Giovanni Luca Botto Cardiology – Electrophysiology Division, Department of Medicine, Ospedale di Circolo Rho, Ospedale Salvini Garbagnate M.se, ASST Rhodense, Milan, Italy
  • Lucia D'Angiolella Research Centre on Public Health (CESP), University of Milano-Bicocca, Monza, Italy
  • Luciana Scalone Charta Foundation, Milan, Italy
  • Roberto De Ponti Department of Heart and Vessels, Ospedale di Circolo-University of Insubria, Varese, Italy
  • Giuseppe Boriani Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Italy
  • Lorenzo Giovanni Mantovani Research Centre on Public Health (CESP), University of Milano-Bicocca, Monza, Italy Value-Based Healthcare Unit, IRCCS Multimedica, Sesto San Giovanni, Italy

DOI:

https://doi.org/10.7175/fe.v22i1S.1486

Keywords:

Health Technology Assessment, Cardioverter Defibrillator, Myocardial Infarction

Abstract

The objective of the present work is to conduct a Health Technology Assessment (HTA) on the use of the Wearable Cardioverter Defibrillator (WCD) in patients at risk of Sudden Cardiac Arrest (SCA) following Myocardial Infarction (MI) or with an explanted Implantable Cardioverter Defibrillator (ICD).

Downloads

Published

2021-04-15

How to Cite

Cortesi, P. A., Botto, G. L., D'Angiolella, L., Scalone, L., De Ponti, R., Boriani, G., & Mantovani, L. G. (2021). Health Technology Assessment on the use of the Wearable Cardioverter Defibrillator in Patients with Myocardial Infarction and with ICD Explant. Farmeconomia. Health Economics and Therapeutic Pathways, 22(1S). https://doi.org/10.7175/fe.v22i1S.1486

Issue

Vol. 22 No. 1S (2021)

Section

Supplement

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
  4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >>